| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 22, 2006
Accepted on October 11, 2006
Department of Endocrinology, St. Vincent's University Hospital, Dublin, Ireland; Education and Research Centre, St. Vincent's University Hospital, Dublin, Ireland; Royal Victoria Eye and Ear Hospital, Dublin, Ireland; The Conway Institute, University College Dublin, Ireland
* To whom correspondence should be addressed. E-mail: tomjcawood{at}eircom.net.
Introduction: Cigarette smoking is the strongest modifiable risk factor for developing thyroid associated ophthalmopathy (TAO), and the severity of TAO is related to the current number of cigarettes smoked per day. We aimed to establish the effects of cigarette smoke extract (CSE) on an in vitro model of TAO.
Methods: Orbital tissue was taken during surgery from ten patients with TAO and nine control subjects. Orbital fibroblasts (OFs) were cultured, exposed to CSE, and inter-cellular adhesion molecule 1 (ICAM1) expression measured by flow cytometry. Glycosaminoglycan production was measured by hyaluronic acid ELISA. OFs were grown in adipogenic media ± CSE and/or IL1, and the degree of adipogenesis was quantified.
Results: Fibroblasts from patients with TAO and controls showed similar responses. ICAM1 expression was not affected by CSE. Hyaluronic acid production was stimulated by CSE in a dose-dependent manner (correlation coefficient 0.978, P = 0.022), with 5%CSE causing an increase of 44% (P = 0.001). CSE increased adipogenesis in a dose-related manner, as did IL1. The effects of CSE and IL1 on adipogenesis were synergistic, with the degree of adipogenesis in the well containing both 5%CSE and 0.1ng/ml IL1 being double the magnitude of the sum of the values obtained from either stimulus alone (P < 0.001). Addition of an anti-IL1 antibody to the well containing both 5%CSE and 0.1ng/ml IL1 reduced the degree of adipogenesis by 82% (P < 0.001).
Conclusion: These findings may help explain how cigarette smoking has a detrimental effect in TAO, and suggests that IL1 may be an attractive therapeutic target in TAO.
This article has been cited by other articles:
![]() |
N Lois, E Abdelkader, K Reglitz, C Garden, and J G Ayres Environmental tobacco smoke exposure and eye disease Br. J. Ophthalmol., October 1, 2008; 92(10): 1304 - 1310. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |